SHL Telemedicine Ltd. (SHLT)
2.80
-0.10 (-3.45%)
At close: Jan 14, 2025, 3:05 PM
2.80
0.00%
After-hours Jan 14, 2025, 03:05 PM EST
undefined% (undefined)
| Bid | 2.56 |
| Market Cap | 45.90M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -5.28 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 3 |
| Volume | 4,666 |
| Avg. Volume (20D) | 21,621 |
| Open | 2.87 |
| Previous Close | 2.90 |
| Day's Range | 2.71 - 2.90 |
| 52-Week Range | 2.54 - 8.58 |
| Beta | undefined |
About SHLT
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device f...
Sector Healthcare
IPO Date Apr 3, 2023
Employees 583
Stock Exchange NASDAQ
Ticker Symbol SHLT
Website https://www.shl-telemedicine.com
Analyst Forecast
According to 1 analyst ratings, the average rating for SHLT stock is "Buy." The 12-month stock price forecast is $11, which is an increase of 292.86% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
